We are pleased to announce the call for proposals for the newly
formed Pfizer CTI partnership with Washington University. Pfizer’s
Centers for Therapeutic Innovation, or CTI, is a unique program that
collaborates with leading academic medical centers, the NIH, and foundations to
speed the translation of novel targets to the clinic. As part of the
agreement, Washington University researchers will be able to apply for funding
to support specific research projects. If a project is selected, School of
Medicine investigators would have access to Pfizer’s resources, scientific
equipment, and opportunities to collaborate with Pfizer scientists, who have
extensive expertise in drug development. Representatives from Pfizer CTI
recently visited Washington University to become acquainted with the breadth
and depth of the research here.
There will be two calls for proposals annually, with April 2017
the first this year. Specific criteria to this call for proposals include
- The therapeutic interests of this round include
oncology, inflammation and immune disorders, cardiovascular and metabolic
diseases, neuroscience and rare monogenetic disorders.
- The anticipated clinical modality should be large
molecule bio-therapeutics (antibodies, proteins, peptides, ADCs, fusions)
Please see the CTI flier for more information on the program and the Pre-Proposal Template for details about the pre-proposal.
- A non-confidential 2-3 page Pre-proposal is submitted
17th, 8am to firstname.lastname@example.org.
This preproposal will be reviewed by the Office of Technology Management
to protect your intellectual property and ensure there are no accidental
- Following a review period of approximately 10 weeks,
Pfizer CTI will invite some investigators to submit a full proposal. At
this stage investigators will also a paired with a Pfizer co-PI.
- After a second review period of approximately 10 weeks,
a final decision will be reached regarding which projects Pfizer CTI will
A Washington University committee is in place to help our
investigators navigate this new funding opportunity and increase their
likelihood of success. We encourage you to reach out to the committee members
to discuss your pre-proposal before submitting.
This committee is made up of:
Karen Seibert email@example.com
Thad Stappenbeck firstname.lastname@example.org
Michael Kinch email@example.com
Nichole Mercier firstname.lastname@example.org
Pat Gregory email@example.com
An informational Webinar will also be held by Pfizer CTI on
March 21st at 2pm to allow applicants to ask questions. Click here for login information. (IE users, is prompted to enter your credentials, click cancel and the Word document will open.)